Opella Central & Eastern Europe

Certified B Corporation
Standards version

1.6

Headquarters

Pest County, Hungary

Certified Since

October 2024

Industry

Pharmaceutical products

Sector

Manufacturing

Operates In

Czech Republic,

Hungary,

Poland,

Romania,

Slovakia,

Ukraine

Opella Central & Eastern Europe (Opella Healthcare Poland Sp. z.o.o PL, Opella Healthcare Hungary K.F.T. HU, Opella Healthcare Commercial Hungary K.F.T. HU, Opella Healthcare Czech s.r.o. CZ, Opella Healthcare Slovakia s.r.o. SK, Opella Healthcare Ukraine, and Opella Healthcare Romania S.R.L. RO) offers a diverse product line of over-the-counter medicines, food supplements and medical devices across several categories, including digestive health, cough and cold, pain and mental health. Our strong portfolio of brands includes Magne B6, Essentiale, No-Spa. Through our consumer-led, science-based products we enable people to champion better self-care and are investing in community well-being, because we believe healthier people and a healthier planet go hand in hand. As guardians of personal health, we are dedicated to growing our business while helping improve the health of people and the planet.

Overall B Impact Score

Based on the B Impact assessment, Opella Central & Eastern Europe earned an overall score of 93.9. The median score for ordinary businesses who complete the assessment is currently 50.9.
93.9
93.9 Overall B Impact Score
80 Qualifies for B Corp Certification
50.9 Median Score for Ordinary Businesses

Governance 13.6


Workers 31.2


Community 18.3


Environment 15.9


Customers 14.6



Additional Documentation

Opella CEE - Controversial Industry Statement (2024)

Opella CEE (Central and Eastern Europe) - Disclosure Report (2024)

Opella CEE - Score Aggregation Methodology & Brand List

Opella CEE - Transparent Assessment (2024)